Related Experiment Video
Updated: Mar 26, 2026

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory
M Fá1, D Puzzo1,2, R Piacentini3
1Department of Pathology and Cell Biology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, 630 W 168th St. New York, NY 10032 USA.
Abstract:
Non-fibrillar soluble oligomeric forms of amyloid-β peptide (oAβ) and tau proteins are likely to play a major role in Alzheimer's disease (AD). The prevailing hypothesis on the disease etiopathogenesis is that oAβ initiates tau pathology that slowly spreads throughout the medial temporal cortex and neocortices independently of Aβ, eventually leading to memory loss. Here we show that a brief exposure to extracellular recombinant human tau oligomers (oTau), but not monomers, produces an impairment of long-term potentiation (LTP) and memory, independent of the presence of high oAβ levels. The impairment is immediate as it raises as soon as 20 min after exposure to the oligomers. These effects are reproduced either by oTau extracted from AD human specimens, or naturally produced in mice overexpressing human tau. Finally, we found that oTau could also act in combination with oAβ to produce these effects, as sub-toxic doses of the two peptides combined lead to LTP and memory impairment. These findings provide a novel view of the effects of tau and Aβ on memory loss, offering new therapeutic opportunities in the therapy of AD and other neurodegenerative diseases associated with Aβ and tau pathology.
Insights
Extracellular tau oligomers (oTau) rapidly impair memory and long-term potentiation (LTP) independently of amyloid-beta (oAβ). This suggests oTau as a potential therapeutic target for Alzheimer
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Soluble oligomeric forms of amyloid-beta peptide (oAβ) and tau proteins are implicated in Alzheimer's disease (AD) pathogenesis.
- The current hypothesis suggests oAβ initiates tau pathology, leading to memory loss.
- The independent role of tau pathology in AD progression requires further investigation.
Purpose of the Study:
- To investigate the direct impact of extracellular tau oligomers (oTau) on memory and synaptic plasticity.
- To determine if oTau can induce cognitive deficits independent of amyloid-beta (oAβ) presence.
- To explore the combined effects of oTau and oAβ on cognitive function.
Main Methods:
- Exposure of biological systems to extracellular recombinant human tau oligomers (oTau) and monomers.
- Assessment of long-term potentiation (LTP) and memory function.
- Utilizing oTau extracted from AD human specimens and naturally produced oTau in transgenic mice.
Main Results:
- Brief exposure to oTau, but not monomers, caused immediate impairment of LTP and memory within 20 minutes.
- These effects were observed independently of high oAβ levels.
- Combined sub-toxic doses of oTau and oAβ synergistically impaired LTP and memory.
Conclusions:
- Extracellular oTau directly induces synaptic and memory deficits, independent of oAβ.
- oTau plays a significant role in AD-associated memory loss.
- These findings highlight oTau as a potential therapeutic target for AD and related neurodegenerative diseases.
More Related Videos
Related Concept Videos
Long-term Potentiation
Hebbian LTP
LTP can occur when...
Long-term Potentiation
Long-term Depression
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

